Author

Swena Patel

University of California, Irvine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Afshana QuadiriiD· 2 shared Aziz Alami ChentoufiiD· 2 shared Emma Jane Liao· 2 shared Etinosa Omorogieva· 2 shared Hawa VahediD· 2 shared Jimmy Tadros· 2 shared Lauren Lau· 2 shared Lbachir BenMohamediD· 2 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Afshana QuadiriORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Pan-Beta-Coronavirus Vaccine Bearing Conserved and Asymptomatic B- and T-Cell Epitopes Protect Against Highly Pathogenic Delta and Highly Transmissible Omicron SARS-CoV-2 Variants of Concern.

Hawa Vahed, Swayam Prakash, Afshana Quadiri, Izabela Coimbra Ibraim, Etinosa Omorogieva, Swena Patel, Jimmy Tadros, Emma Jane Liao, Lauren Lau, Aziz Alami Chentoufi, Anthony B. Nesburn, Baruch D. Kuppermann, Jeffrey B. Ulmer, Daniel Gil, Lbachir BenMohamed

This paper develops a multi-epitope vaccine targeting conserved B- and T-cell epitopes from SARS-CoV-2, showing protection against Delta and Omicron variants in a mouse model.

Human Vaccines & Immunotherapeutics · Jul 4, 2025Peer-reviewedImmunology

CXCL13/CXCR5 Chemokine Axis Promotes CXCR5+CD19+ B-Cell and Follicular/Effector CXCR5+CD4+ T-Cell Responses in the Lungs Associated with Protection from Severe and Fatal COVID-19 Following Infection with Pathogenic SARS-CoV-2 Delta Variant

Hawa Vahed, Aziz Alami Chentoufi, Swayam Prakash, Afshana Quadiri, Sweta Karan, Yassir Lekhbach, Etinosa Omorogieva, Swena Patel, Jimmy Tadros, Emma Jane Liao, Lauren Lau, Delia F. Tifrea, Lbachir BenMohamed

This study shows that CXCL13 deficiency in mice worsens SARS-CoV-2 infection, with higher viral load, lung damage, and reduced B and T cell responses.

bioRxiv · Apr 18, 2025 · PreprintImmunology